HC directive on Wockhardt's plea

Image
Press Trust of India Chennai
Last Updated : Oct 05 2013 | 11:15 PM IST
Madras High Court today directed the concerned Drugs Controller to take inventory of banned dextropropoxyphene, a pain killer, held in the warehouses of its manufacturer Wockhardt and distributors within two weeks and keep them sealed separately.
Justice K K Sasidharan gave the direction while disposing of miscellaneous petitions by Wockhardt Limited and a distributor.
The two in separate petitions submitted that consequent to the Central Government's ban, their warehouses, where the other drugs were also kept, had been sealed inspite of them stopping production of the banned drug.
The sealing of warehouses affected their business activity as a whole, the petitioners said pleading for relief.
The Centre in May last banned the manufacture and sale of dextropropoxyphene, sold under the brand Proxyvon, in view of its alleged harmful effects.
In his order, the Judge said the company was restrained from manufacturing or marketing dextyropropoxyphene till the disposal of the main petition challenging the centre's notification banning the drug.
He directed the company to inform the Drugs Controller of India or the concerned Drug Controllers of the State regarding the stocks available with them and the details of warehouses where the above drug in question were stored.
The concerned Drug Controller should take inventory of the drugs within two weeks and thereafter the package should be sealed and it be kept separately in the warehouses.
The inventory of the drugs taken by the Drug Controller and duly signed by the representatives of the manufacturer or Distributor should be retained by the concerned Drugs Controller.
The Judge further directed the authorities not to take any penal action in view of the direction to take inventory till the disposal of the main writ petition.
However, he said if it was found that the manufacturer was in possession of the suspended drug or its preparations other than the quantity already disclosed, authorities could seize the same and take appropriate action.
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Oct 05 2013 | 11:15 PM IST

Next Story